Latest California Healthline Stories
Pharma’s Take On The Pelosi Drug-Pricing Bill: Fair Warning Or Fearmongering?
The pharmaceutical industry’s argument that capping drug prices would compromise drug innovation stands “on very shaky ground.”
Did Joe Biden Overstate Democratic Voters’ Opposition To ‘Medicare For All’?
The term “vast” sets a high bar.
Do 160 Million Americans Really Like Their Health Plans? Kind Of
Former Vice President Joe Biden’s claim during the latest Democratic presidential debate relies on a squishy number, and context matters.
Surgeon General’s Marijuana Warning Omits Crucial Context
Surgeon General Jerome Adams said the drug has a “unique impact” on the developing brain — technically true, but neglecting a vital comparison to other drugs, as well as shortcomings in the existing research.
Big picture remains hazy, but these numbers add up.
Refereeing Pete Buttigieg, Elizabeth Warren On Public Support For ‘Medicare For All’
Polling supports Buttigieg’s claim.
Warren Trots Out Her Own Harvard Law Research
Warren’s claim on health insurance and bankruptcy is narrow enough to hold up.
Biden Gets Too Specific On ‘Medicare For All’ Tax Hikes
It comes down to questionable methodology.
Health Care Stayed Front And Center At Democratic Debate
The topic, which polls show is top of mind among voters, kept returning throughout the fourth debate of Democratic presidential candidates.
Trump Speech Offers Dizzying Preview Of His Health Care Campaign Strategy
The president’s outline of key health policy concerns touched on a variety of hot-button issues from drug prices to immigration.